Entos Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Canada · 51-200 Employees
View Company Info for Free
Overview
Headquarters
10230 Jasper Ave Unit 4550, Edmonton, Al...Phone Number
(800) 727-0884Website
www.entospharma.comRevenue
$18.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Entos Pharmaceuticals
Entos Pharmaceuticals is dedicated to advancing genetic medicine through its innovative Fusogenix PLV technology, which facilitates the safe and effective delivery of nucleic acid therapies. The company focuses on developing precision therapies that address significant clinical unmet needs, improving the lives of patients and their families. Their platform utilizes advanced AI for targeted delivery to specific organs, tissues, and cells. Entos aims to deliver on the promise of genetic medicines, fostering a future where diseases can be prevented or cured at the source.Explore more
Entos Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Entos Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Entos Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Entos Pharmaceuticals recently announced quarterly report
Funding: Get notified immidiatlly once Entos Pharmaceuticals has new funding data
Click to see if Entos Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Entos Pharmaceuticals launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Entos Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Entos Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Entos Pharmaceuticals
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Entos Pharmaceuticals
Compare insights from companies similar to Entos Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Entos Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Entos Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Entos Pharmaceuticals.
Entos Pharmaceuticals financials insights
Gather financial insights about Entos Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Other Financing Round
$77.5M
Entos Pharmaceuticals Tech Stack
A closer look at the technologies used by Entos Pharmaceuticals
Most Recent Scoops
Facilities Relocation / Expansion
Entos Pharmaceuticals is planning to move offices in September 2025. The move will impact approximately 8 employees at the existing office located at Enterprise Square, 10230 Jasper Ave, Edmonton, AB.
Facilities Relocation/Expansion
Funding
Entos Pharmaceuticals has secured an undisclosed amount in additional funding from investor CureDuchenne Ventures.
Funding
Funding
Funding
Project
Product Development, Medical Research, Pharmaceuticals, Clinical Operations
Partnership
Partnership, Research & Development, Intellectual Property, Legal Affairs, Medical Research
Entos Pharmaceuticals News & Media
Entos Pharmaceuticals Announces Plans To Build 198M Facility In Alberta Canada
Entos® Pharmaceuticals (Entos), a clinical-stage genetic medicines company committed to using its Fusogenix™ PLV™ technology to develop cures, has announced a $62 million investment from the Government of Canada. This funding leverages a previously announced $15.5 million awarded to Entos from the Government of Alberta.Entos Pharmaceuticals Announces $198.5 Million Partnership with the Governments of Canada and Alberta to Accelerate Biomanufacturing of Fusogenix PLV Next Generation Therapeutics
EDMONTON, Alberta--(BUSINESS WIRE)-- #Fusogenix--Entos® Pharmaceuticals (Entos), a clinical-stage genetic medicines company committed to using its Fusogenix™ PLV™ technology to develop cures and improve the lives of patients and their families, announced a $62 million investment from the Government of Canada. This further leverages the previously announced $15.5 million awarded to Entos from the Government of Alberta. The $77.5 million total investment will support a $198.5 million project to crEntos Pharmaceuticals Awarded $4 Million USD in Funding from the California Institute for ...
Entos® Pharmaceuticals (Entos), a clinical-stage genetic medicines company committed to using its Fusogenix™ PLV™ technology to develop cures and imprEntos Pharmaceuticals Awarded $4 Million USD in Funding from the California Institute for Regenerative Medicine (CIRM) for its Congenital Generalized Lipodystrophy Program
SAN DIEGO--(BUSINESS WIRE)-- #California--Entos® Pharmaceuticals (Entos), a clinical-stage genetic medicines company committed to using its Fusogenix™ PLV™ technology to develop cures and improve the lives of patients and their families, announced today that the California Institute for Regenerative Medicine (CIRM) has awarded the company a $4M USD grant. The funds will support the completion of IND-enabling activities for the development of ENTLEP001, a durable genetic medicine for the treatmen
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Entos Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Entos Pharmaceuticals is dedicated to advancing genetic medicine through its innovative Fusogenix PLV technology, which facilitates the safe and effective delivery of nucleic acid therapies. The company focuses on developing precision therapies that address significant clinical unmet needs, improving the lives of patients and their families. Their... Read More
